Component
Ammonium molybdate
Ammonium molybdate. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Ammonium molybdate improved the clinical condition, reversed the sulfur-handling defect and normalized urate production in the reported case.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/molybdenum-research/6795919.publisher-abstract.txt", "locator": "Exact primary publisher abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d2838a46a598539818059c1a1f8295e283334afced15326a6b5ba1a6104cbfd7", "start_char": 0, "end_char": 1820, "text_sha256": "d2838a46a598539818059c1a1f8295e283334afced15326a6b5ba1a6104cbfd7"}
- experimental_model
- Single case during prolonged total parenteral nutrition
- exposure
- Prolonged parenteral nutrition followed by ammonium molybdate
- limitations
- Rare single case. The paper reports 300 micrograms/day ammonium molybdate, not 300 micrograms elemental molybdenum. Historical observation, not a general regimen.
- nutrient_topic
- Molybdenum research collection; topical membership is not evidence of a direct dietary effect. · Molybdenum
- organism
- Homo sapiens
- plain_language
- Replacement helped this documented acquired shortage.
- primary_references
- [mo-p6795919] Amino acid intolerance during prolonged total parenteral nutrition reversed by molybdate therapy. (1981). https://pubmed.ncbi.nlm.nih.gov/6795919/ DOI: 10.1093/ajcn/34.11.2551
- tissue_or_cell_type
- Systemic symptoms; plasma and urine
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Molybdenum: cofactor assembly, sulfur metabolism and nutrient interactions (2026-09-17) · lines 1145–1156
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Single case during prolonged total parenteral nutrition · source_derived_draft · unverified_draft
### mo-tpn-repletion Ammonium molybdate improved the clinical condition, reversed the sulfur-handling defect and normalized urate production in the reported case. Condition category: nutrient_deficiency nutrient_topic: Molybdenum research collection; topical membership is not evidence of a direct dietary effect. plain_language: Replacement helped this documented acquired shortage. organism: Homo sapiens tissue_or_cell_type: Systemic symptoms; plasma and urine experimental_model: Single case during prolonged total parenteral nutrition limitations: Rare single case. The paper reports 300 micrograms/day ammonium molybdate, not 300 micrograms elemental molybdenum. Historical observation, not a general regimen. exposure: Prolonged parenteral nutrition followed by ammonium molybdate evidence_span: {"source_cache": "artifacts/molybdenum-research/6795919.publisher-abstract.txt", "locator": "Exact primary publisher abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d2838a46a598539818059c1a1f8295e283334afced15326a6b5ba1a6104cbfd7", "start_char": 0, "end_char": 1820, "text_sha256": "d2838a46a598539818059c1a1f8295e283334afced15326a6b5ba1a6104cbfd7"} [mo-p6795919] Amino acid intolerance during prolonged total parenteral nutrition reversed by molybdate therapy. (1981). https://pubmed.ncbi.nlm.nih.gov/6795919/ DOI: 10.1093/ajcn/34.11.2551
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.